Edoxaban treatment in atrial fibrillation in routine clinical care: One‐year outcomes of the prospective observational ETNA‐AF study in South Korean patients

Abstract Background The real‐world outcomes of edoxaban treatment in patients with atrial fibrillation (AF) were analyzed in the ETNA‐AF (Edoxaban Treatment in Routine Clinical Practice) study involving data from multiple regional registries. This report addresses effectiveness and safety of edoxaba...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Eue‐Keun Choi, Jong‐Il Choi, Hyoung‐Seob Park, Gyo‐Seung Hwang, Boyoung Joung, Jong‐Youn Kim, Dae‐Hyeok Kim, Dong Gu Shin, Hyung Wook Park
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2023-08-01
Edice:	Journal of Arrhythmia
Témata:	major bleeding non‐vitamin K antagonist oral anticoagulants real‐world registry stroke prevention
On-line přístup:	https://doi.org/10.1002/joa3.12878
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!